Hemoglobin C DiseaseSymptoms, Doctors, Treatments, Advances & More
Hemoglobin C Disease Overview
Learn About Hemoglobin C Disease
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Ogobara Doumbo practices practicing medicine in Bamako, Mali. Doumbo is rated as an Elite expert by MediFind in the treatment of Hemoglobin C Disease. They are also highly rated in 9 other conditions, according to our data. Their clinical expertise encompasses Malaria, Hemoglobin C Disease, Primary Amebic Meningoencephalitis, and Sepsis.
ETSU Pediatrics- St. Jude's Clinic
Marcela Popescu is a Hematologist and an Oncologist practicing medicine in Johnson City, Tennessee. Dr. Popescu is rated as an Experienced provider by MediFind in the treatment of Hemoglobin C Disease. She is also highly rated in 7 other conditions, according to our data. Her clinical expertise encompasses Hereditary Spherocytosis, Von Willebrand Disease (VWD), Evans Syndrome, and Hemophilic Arthropathy. Dr. Popescu is board certified in American Board Of Pediatrics.
Advocate Medical Group Primary Care
Cherie Hawkins is a primary care provider, practicing in Family Medicine in Chicago, Illinois. Dr. Hawkins is rated as an Experienced provider by MediFind in the treatment of Hemoglobin C Disease. Her clinical expertise encompasses Diabetic Hyperglycemic Hyperosmolar Syndrome, Kearns-Sayre Syndrome, Glucocorticoid-Remediable Aldosteronism, and Familial Hypertension. Dr. Hawkins is board certified in American Osteopathic Board Of Family Physicians, Family Practice.
Summary: The primary objective of this study is to evaluate a potential behavioral intervention (MED-Go app). To meet this objective, the researchers will conduct a pilot randomized controlled trial to test the feasibility and acceptability of MED-Go app in adolescents and young adults (AYA) with sickle cell disease (SCD). The long-term goal of this research is to promote medication adherence behavior and ...

